DETERMINATION OF CANNABINOIDS, THC AND THC-COOH, IN ORAL FLUID USING AN AGILENT 6490 TRIPLE QUADRUPOLE LC/MS

Similar documents
A FORENSIC TOXICOLOGY METHOD FOR THE DETERMINATION OF DESOMORPHINE, HEROIN, METHADONE, BUPRENORPHINE AND METABOLITES IN URINE USING LC/MS QQQ

Analysis of anti-epileptic drugs in human serum using an Agilent Ultivo LC/TQ

A Robustness Study for the Agilent 6470 LC-MS/MS Mass Spectrometer

ETHYL GLUCURONIDE DETERMINATION IN HAIR AS AN INDICATOR OF CHRONIC ALCOHOL ABUSE: A FULLY VALIDATED METHOD BY GC-EI-MS/MS

Efficient Quantitative Analysis of THC and Metabolites in Human Plasma Using Agilent Captiva EMR Lipid and LC-MS/MS

LC-MS/MS analysis of Chlorates in Milk and Whey Powder using the Agilent 6470 QQQ

Amphetamines, Phentermine, and Designer Stimulant Quantitation Using an Agilent 6430 LC/MS/MS

Cannabinoid Quantitation Using an Agilent 6430 LC/MS/MS

Vitamin D Metabolite Analysis in Biological Samples Using Agilent Captiva EMR Lipid

Ultrafast Analysis of Benzodiazepines in Urine by the Agilent RapidFire High-Throughput Triple Quadrupole Mass Spectrometry System

Jennifer P. Pascali, PhD. dtolabs, Resana (TV)

Determination of β2-agonists in Pork Using Agilent SampliQ SCX Solid-Phase Extraction Cartridges and Liquid Chromatography-Tandem Mass Spectrometry

Qualitative and quantitative determination of cannabinoid profiles and potency in CBD hemp oil using LC/UV and Mass Selective Detection

Two-Dimensional LC/MS/MS to Reduce Ion Suppression in the Determination of Cannabinoids in Blood Plasma

UPLC/MS Monitoring of Water-Soluble Vitamin Bs in Cell Culture Media in Minutes

Reduced Ion Suppression and Improved LC/MS Sensitivity with Agilent Bond Elut Plexa

Authors. Abstract. Forensic Toxicology. Irina Dioumaeva, John M. Hughes Agilent Technologies, Inc.

Determination of Amantadine Residues in Chicken by LCMS-8040

LC/MS/MS of Trichothecenes and Zearalenone in Wheat Using Different Sample Prep Methods

Cannabinoid Profiling and Quantitation in Hemp Extracts using the Agilent 1290 Infinity II/6230B LC/TOF system

SPE-LC-MS/MS Method for the Determination of Nicotine, Cotinine, and Trans-3-hydroxycotinine in Urine

Application Note LCMS-108 Quantitation of benzodiazepines and Z-drugs in serum with the EVOQ TM LC triple quadrupole mass spectrometer

Quantitative Analysis of THC and Main Metabolites in Whole Blood Using Tandem Mass Spectrometry and Automated Online Sample Preparation

Application Note. Author. Abstract. Introduction. Food Safety

Extended Mass Range Triple Quadrupole for Routine Analysis of High Mass-to-charge Peptide Ions

Quantification of lovastatin in human plasma by LC/ESI/MS/MS using the Agilent 6410 Triple Quadrupole LC/MS system

Extraction of Multiple Mycotoxins From Nuts Using ISOLUTE Myco prior to LC-MS/MS Analysis

4.5 Minute Analysis of Benzodiazepines in Urine and Whole Blood Using LC/MS/MS and an Ultra Biphenyl Column

Analysis of mycotoxins in food matrices using the Agilent Ultivo Triple Quadrupole LC/MS

Quantitative Analysis of Opiates in Urine Using RRHT LC/MS/MS. Application. Authors. Introduction. Abstract. Forensics

Determination of Benzodiazepines in Urine by CE-MS/MS

Rapid and Accurate LC-MS/MS Analysis of Nicotine and Related Compounds in Urine Using Raptor Biphenyl LC Columns and MS-Friendly Mobile Phases

Mycotoxin Analysis in Peanut Butter Using Captiva EMR Lipid Cleanup and LC/MS/MS

Rapid and Robust Detection of THC and Its Metabolites in Blood

Quantitative Analysis of Underivatized Amino Acids in Plant Matrix by Hydrophilic Interaction Chromatography (HILIC) with LC/MS Detection

All stocks and calibration levels were prepared in water: methanol (50:50) v/v to cover range of all steroid concentrations (refer Table 1).

Extraction of Multiple Mycotoxins From Grain Using ISOLUTE Myco prior to LC-MS/MS Analysis

High-Throughput, Cost-Efficient LC-MS/MS Forensic Method for Measuring Buprenorphine and Norbuprenorphine in Urine

Vitamin D3 and related compounds by ESI and APCI

Analysis of Testosterone, Androstenedione, and Dehydroepiandrosterone Sulfate in Serum for Clinical Research

Detection of Cannabinoids in Oral Fluid with the Agilent 7010 GC-MS/MS System

LC-MS/MS Method for the Determination of Tenofovir from Plasma

A RAPID AND SENSITIVE ANALYSIS METHOD OF SUDAN RED I, II, III & IV IN TOMATO SAUCE USING ULTRA PERFORMANCE LC MS/MS

Analyze Barbiturates in Urine with Agilent 6430 LC/MS/MS and Poroshell 120 EC-C18

Quantitative Method for Amphetamines, Phentermine, and Designer Stimulants Using an Agilent 6430 LC/MS/MS

A Novel Solution for Vitamin K₁ and K₂ Analysis in Human Plasma by LC-MS/MS

Transferring a Method for Analysis of DNPH-Derivatized Aldehydes and Ketones from HPLC to UHPLC

High-Throughput Quantitative LC-MS/MS Analysis of 6 Opiates and 14 Benzodiazepines in Urine

LC/MS Method for Comprehensive Analysis of Plasma Lipids

Robust extraction, separation, and quantitation of structural isomer steroids from human plasma by SPE-UHPLC-MS/MS

Dry eye disease commonly known as atopic keratoconjunctivitis is an autoimmune disease of

Fast and simultaneous analysis of ethanol metabolites and barbiturates using the QTRAP 4500 LC-MS/MS system

Analysis of Acrylamide in French Fries using Agilent Bond Elut QuEChERS AOAC kit and LC/MS/MS

Extraction of Synthetic and Naturally Occurring Cannabinoids in Urine Using SPE and LC-MS/MS

LC-MS/MS Method for the Determination of 21 Opiates and Opiate Derivatives in Urine

Rapid Analysis of Water-Soluble Vitamins in Infant Formula by Standard-Addition

Extraction of a Comprehensive Steroid Panel from Human Serum Using ISOLUTE. SLE+ Prior to LC/MS-MS Analysis

Mycotoxin Analysis in Infant Formula Using Captiva EMR Lipid Cleanup and LC/MS/MS

Modified QuEChERS for HILIC LC/MS/MS Analysis of Nicotine and Its Metabolites in Fish

Detection of Cotinine and 3- hydroxycotine in Smokers Urine

Analysis of Cholesterol-Lowering Drugs (Statins) Using Dried Matrix Spot Technology

Maria João Mendes Mendonça Barreira Department of Health Promotion and Chronic Deseases, INSA

Modernizing the Forensic Lab with LC-MS/MS Technology

Quantitative Analysis of Vit D Metabolites in Human Plasma using Exactive System

Analysis of Rosuvastatin in Dried Blood Spot and Plasma Using ACQUITY UPLC with 2D Technology

Application Note. Small Molecule Pharmaceuticals. 2-Ethyl-2-phenylmalonamide Ethosuximide Primidone Carbamazepine. Carbamazepine-

Shuguang Li, Jason Anspach, Sky Countryman, and Erica Pike Phenomenex, Inc., 411 Madrid Ave., Torrance, CA USA PO _W

Determination of Amphetamine and Derivatives in Urine

Fast and easy separation of 23 drugs of abuse. including high, stable resolution of isobaric opioids from human urine by UHPLC-MS/MS

Separation of Polyphenols by Comprehensive 2D-LC and Molecular Formula Determination by Coupling to Accurate Mass Measurement

Extraction of Aflatoxin M1 From Infant Formula Using ISOLUTE Myco SPE Columns prior to LC-MS/MS Analysis

Supporting Information

Extraction of 11-nor-9-carboxy-tetrahydrocannabinol from Hydrolyzed Urine by ISOLUTE. SLE+ Prior to GC/MS Analysis

SCIEX Vitamin D 200M Assay for the Topaz System

Development of a Bioanalytical Method for Quantification of Amyloid Beta Peptides in Cerebrospinal Fluid

Gradient Elution LC-MS/MS Determination of Gefitinib in Rat Plasma and its Pharmacokinetic Study

Quantitative Analysis of Drugs of Abuse in Urine using UHPLC Coupled to Accurate Mass AxION 2 TOF Mass Spectrometer

Application Note. Agilent Application Solution Analysis of ascorbic acid, citric acid and benzoic acid in orange juice. Author. Abstract.

Key Advantages of Comprehensive Cannabis Analysis

Accuracy and Precision. Intra- and inter-assay accuracy and precision for both rifapentine

UPLC-MS/MS Analysis of Azole Antifungals in Serum for Clinical Research

Evaluation of an LC-MS/MS Research Method for the Analysis of 33 Benzodiazepines and their Metabolites

Determination of red blood cell fatty acid profiles in clinical research

The Investigation of Factors Contributing to Immunosuppressant Drugs Response Variability in LC-MS/MS Analysis

[application note] Simultaneous detection and quantification of D 9 THC, 11-OH-D 9 T H C and D 9 THC-COOH in whole blood by GC tandem quadrupole MS

Neosolaniol. [Methods listed in the Feed Analysis Standards]

Validation Report 23 B

Matrix Factor Determination with the Waters Regulated Bioanalysis System Solution

Determination of Gamma-Hydroxy-Butyrate (GHB) in Biological Samples

The New 6495 Triple Quadrupole LC/MS

Abstract. Introduction

Workflow for Screening and Quantification of the SAMHSA (NIDA) Panel in Urine Using UHPLC-TOF

A Simple and Accurate Method for the Rapid Quantitation of Drugs of Abuse in Urine Using Liquid Chromatography

Validation of a Benzodiazepine and Z-Drug Method Using an Agilent 6430 LC/MS/MS

Breaking the Sensitivity Barrier in Triple Quad LC/MS Performance

Comprehensive Forensic Toxicology Screening in Serum using On-Line SPE LC-MS/MS

Quantitative Determination of Drugs of Abuse in Human Plasma and Serum by LC/MS/MS Using Agilent Captiva EMR Lipid Cleanup

Extraction of 25-hydroxy Vitamin D from Serum Using ISOLUTE. PLD+ Prior to LC-MS/MS Analysis

2D-LC as an Automated Desalting Tool for MSD Analysis

Transcription:

FORENSICS AND TOXICOLOGY ANALYSIS DETERMINATION OF CANNABINOIDS, THC AND THC-COOH, IN ORAL FLUID USING AN AGILENT 6490 TRIPLE QUADRUPOLE LC/MS Solutions for Your Analytical Business Markets and Applications Programs Abstract Solution Note Forensics Author(s) Jennifer P. Pascali DTOLabs, Analytical Excellence Centre, authorized Agilent Technologies Partner Lab, Resana (TV), Italy. A simple and rapid method was developed for the quantitation of cannabinoids, namely Tetrahydrocannabinol (THC) and its metabolite Carboxytetrahydrocannabinol (THC-COOH), in oral fluid (OF) using an Agilent 6490 Triple Quadrupole LC/MS system. The method was validated according to forensic guidelines and presented excellent data in terms of selectivity, sensitivity and linearity. Also an evaluation of the matrix effect is reported. The results confirmed the suitability of the present method in forensic routine analysis of cannabinoids in oral fluid. Introduction Oral fl uid (OF) is a new biological matrix for clinical and forensic drug testing, offering easy and non-invasive sample collection mainly accomplished with commercial disposable devices. Due to a stronger correlation than urine with blood concentrations, screening based on OF is greatly gaining value in DUID (Driving under the infl uence of drugs) programs worldwide [1]. Furthermore cannabinoids are usually the most prevalent analytes in illicit drug testing and for this reason application of OF testing requires suffi cient reliable data to support sensitive and specifi c cannabinoid detection for forensic purposes [2]. Cannabinoids analysis has been historically performed using GC-MS technology, either single quadrupole or triple quadrupole systems. However in the last decade the role of LC-MS/MS in modern forensic toxicology laboratories has gained more relevance because of less extensive sample preparation, reliable results and versatility. This application note describes a simple fully validated LC-MS/MS method for the determination of Tetrahydrocannabinol (THC) and its metabolite Carboxytetrahydrocannabinol (THC-COOH) in OF. Sample preparation is fast and is based on the dilute and shoot approach. Results are presented in terms of selectivity, matrix effect, linearity and reproducibility. 1

Experimental Setup Materials Oral fluid samples were from healthy volunteers gathered from the people in the laboratory who denied any drug consumption. Samples were collected by spitting. Water was of milli-q grade from Sartorius arium pro VF UF, Goettingen, Germany. Acetonitrile was of LC-MS grade from SigmaAldrich, St. Louis, MO, USA. Instrumentation LC MS 1290 Infinity 6490A Chromatographic Conditions Injection volume 5.0 µl Column Agilent ZORBAX Eclipse Plus C18 RRHT, 2.1 mm x 100 mm x 1.8 µm Column thermostat 35 C Needle wash 45 sec Mobile phase A 5 mm ammonium formate + 0.1 % formic acid in water Mobile phase B Acetonitrile + 0.1 % formic acid Flow rate 0.200 ml/min Gradient Initial 30 %B 5.0 minutes 95 %B 8.0 minutes 95 %B 8.1 minutes 30 %B Stop time 8.0 minutes Post run 1.5 minutes MS Parameters Ionisation ESI Jet Stream Polarity (+) Gas temperature 120 C Gas flow 11 L/min Nebuliser pressure 30 psi Sheath gas temperature 400 C Sheath gas flow 12 L/min Capillary voltage 3000 V Nozzle voltage 2000 V Ion funnel voltages 150/100 V MRM transitions THC 315.2g193.2 @20 315.2g123.3 @30 THC-COOH 345.2g299.2 @18 345.2g327.2 @18 THC-COOH-D3 (IS) 348.2g330.2 @18 Sample treatment Oral fluid samples were collected in plastic tubes by spitting. They were then centrifuged at 3000rpm for 10 minutes. The dilute and shoot approach consisted of sample dilution in pure water and direct injection onto the LC-MS system. In order to evaluate matrix effect different dilution factors were considered: 1/5, 1/8, 1/10 in water and 1/5 in methanol. Best results were obtained through a 1/8 dilution in water. Software MassHunter acquisition, qualitative, quantitative 2

Results and Discussion Validation of the method The validation was carried out according to the international forensic guidelines [3]. The method was validated for selectivity, linearity and sensitivity, precision and accuracy. All calculations were performed using the MassHunter software. Matrix effect (ME) In order to quantitatively evaluate ME, the Matuszewski method [4] was adopted. Three dilution factors in water (1/5, 1/8 and 1/10) and one dilution factor in methanol (1/5) were evaluated through standard spiking at three different levels, 0.1, 1.0 and 10 ng/ml, for THC and THC-COOH. Average ME, expressed as coefficient of variation (CV) in %, are reported in Table 1. Compound CV, % Dil 1/5 water CV, % Dil 1/8 water CV, % Dil 1/10 water CV, % Dil 1/5 MeOH THC 15 10 17 35 THC-COOH 4 12 12 15 Table 1. Average CV (%) for THC and THC-COOH in different matrix dilutions. In order to fulfil the CV < 15% requirement for both analytes, the dilution factor of eight in water was selected for method validation. Selectivity Five different samples from volunteers were tested with and without internal standard (IS) in order to determine any endogenous interferent. All tested samples showed no interferent peak at the retention time of the analyte and IS (figures 1A and 1B). A Figure 1 A. OF blank sample spiked with IS (THC-COOH/D3). No interfering peaks were found at the RT of THC. B Figure 1 B. OF blank sample spiked with IS (THC-COOH/D3). No interfering peaks were found at the RT of THC-COOH. 3

Linearity and sensitivity The calibration was evaluated by analysing five replicates of spiked OF at 0.1, 0.25, 0.5, 1.0, 10.0 ng/ml for THC and 0.25, 0.5, 1.0, 10.0 ng/ml for THC-COOH. The peak area response relative to the IS was plotted against concentration for both analytes. The calibration curves, determined by the least squares regression method, were linear over the range, with equations y = 0.186665x + 0.020813, R square 0.9930 and y = 0.272733x 0.001036, R square 0.9977 for THC and THC-COOH respectively [figures 2A and 2B]. A Figure 2 A. THC spiked OF calibration curve. Calibration range 0.1-10 ng/ml. B Figure 2 B. THC-COOH spiked OF calibration curve. Calibration range 0.25-10 ng/ml. 4

The lower limit of quantifications (LLOQ), defined as the lowest concentration with an intraday and inter-day accuracy RSD < 20%, was 0.1 ng/ml in OF (0.0625 pg on column) for THC (figure 3) and 0.25 ng/ml in OF (0.156 pg on column) for THC-COOH (figure 4). The limit of detection (LOD) defined as signal to noise ratio equal to 3 was 0.01 ng/ml in OF for THC (0.00625 pg on column) and 0.1 ng/ml (0.0625 pg on column) in OF for THC-COOH. Signal to noise ratios were calculated with the RMS algorithm in MassHunter quantitative software. Precision and accuracy Precision and accuracy of the method were assessed by analysing spiked OF samples at concentrations of 0.1 (LOQ for THC), 0.25 (LOQ for THC-COOH), 1.0 and 10.0 ng/ml. Five replicates each were analysed on three non-consecutive days. The intra- and inter-day precision and accuracy values fitted the requirements of the forensic guidelines with RSDs always below 20% at the LOQ level and < 15% for higher concentrations. The results of the inter-day testing are summarised in Table 2. Figure 3. THC at 0.1 ng/ml (LLOQ) in spiked OF sample with IS. Figure 4. THC-COOH at 0. 25 ng/ml (LLOQ) in spiked OF sample with IS. Parameter THC 1.1 ng/ml THC-COOH 0.25 ng/ml THC 1.0 ng/ml THC-COOH 1.0 ng/ml THC 10.0ng/mL THC-COOH 10.0 ng/ml Mean (ng/ml) 0.088 0.24 1.06 0.97 9.8 10 SD 0.017 0.03 0.12 0.07 0.3 0.11 RSD, % 19 12 11 7 3 1.1 Bias, % -11-3 +6-3 -2 +0.12 Table 2. Summary of inter-day results for THC and THC-COOH in spiked OF samples. 5

Conclusion The increasing need for testing for drugs of abuse imposes high demands in terms of sensitivity and accuracy of toxicological procedures. An ultra-high performance liquid chromatography/ tandem mass spectrometry method was developed, mainly proposed for screening but also for simultaneous confirmation of cannabinoids in OF samples in a single run. In fact, this developed method demonstrated that it fulfilled the requirements of selectivity, sensitivity, accuracy and precision presented in the international forensic guidelines. The advantage of this LC-MS technique over traditional GC-MS cannabinoids analysis is that it limits sample preparation and exploits the dilute and shoot approach, offering an alternative to time-consuming and labour-intensive sample preparation procedures. 6

References 1. Strano-Rossi S., Castrignanò E., Anzillotti L., Serpelloni G., Mollica R., Tagliaro F., Pascali J.P., di Stefano D., Sgalla R., Chiarotti M., Evaluation of four oral fluid devices (DDS, Drugtest 5000, Drugwipe 5+ and RapidSTAT ) for on-site monitoring drugged driving in comparison with UHPLC-MS/MS analysis, Forensic Sci Int., 221, 1-3, 2012. 2. Lee D., Huestis M.A., Current knowledge on cannabinoids in oral fluid, Drug Test Anal., 2013. 3. Peters F.T., Drummer O.H., Musshoff F., Validation of new methods, Forensic Sci Int, 2-3, 165, 2007. 4. Matuszewski B.K., Constanzer M.L., Chavez-Eng C.M., Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS, Anal Chem., 75, 13, 2003. 7

Agilent Products are for Research Use Only. Not for use in diagnostic procedures. Information, descriptions and specifications in this publication are subject to change without notice. Solutions for your analytical business Markets & Applications Programs www.solutions-to-win.com Agilent Technologies, Inc. 2014 Published in USA, February 14, 2014 5991-3977ENE